Perinatal vertical transmission of antibiotic-resistant bacteria: A systematic review and proposed research strategy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue 8, 2014, Pages 923-928

  Seale, J ^a   Millar, M ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Antibiotic resistance; neonate; vertical transmission

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; ESCHERICHIA COLI; GENE; HUMAN; MICROBIAL COLONIZATION; PERINATAL PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; TET M GENE; TET O GENE; TET Q GENE; TET W GENE; VERTICAL TRANSMISSION;

ANTIBIOTIC RESISTANCE; NEONATE; VERTICAL TRANSMISSION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTENSIVE CARE UNITS, NEONATAL; LABOR, OBSTETRIC; MICROBIAL SENSITIVITY TESTS; PREGNANCY; RISK FACTORS; VAGINA;

EID: 84903544115     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12746     Document Type: Review

References (31)

1. World Health Organisation. The Evolving Threat of Antimicrobial Resistance-Options for Action. Switzerland: World Health Organisation; 2012.
2. U.S. Center for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Georgia: Center for Disease Control and Prevention; 2013.
3. Davies SC,. Annual Report of the Chief Medical Officer, Volume Two, 2011: Infections and the rise of antimicrobial resistance. London: Department of Health, 2013.
4. Sehgal R, Gaind R, Chellani H, Agarwal P,. Extended-spectrum beta lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit. Ann Trop Paediatr 2007; 27: 45-54.
5. Didier C, Streicher MP, Chognot D, Campagni R, Schnebelen A, Messer J, et al. Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics. Eur J Pediatr 2012; 171: 681-7.
6. Cantey JB, Sreeramoju P, Jaleel M, Treviño S, Gander R, Hynan LS, et al. Prompt control of an outbreak caused by extended-spectrum β-lactamase-producing klebsiella pneumoniae in a neonatal intensive care unit. J Pediatr 2013; 163: 672-9.
7. Oteo J, Cercenado E, Vindel A, Bautista V, Fernández-Romero S, Saéz D, et al. Outbreak of multidrug-resistant CTX-M-15-producing Enterobacter cloacae in a neonatal intensive care unit. J Med Microbiol 2013; 62 (Pt 4): 571-5.
8. Gibbs RS, Schrag S, Schuchat A,. Perinatal infections due to group B streptococci. Obstet Gynecol 2004; 104: 1062-76.
9. Friedman S, Shah V, Ohlsson A, Matlow AG,. Neonatal Escherichia coli infections: concerns regarding resistance to current therapy. Acta Paediatr 2000; 89: 686-9.
10. Parm U, Metsvaht T, Sepp E, Ilmoja ML, Pisarev H, Pauskar M, et al. Risk factors associated with gut and nasopharyngeal colonization by common Gram-negative species and yeasts in neonatal intensive care units patients. Early Hum Dev 2011; 87: 391-9.
11. Duman M, Abacioglu H, Karaman M, Duman N, Ozkan H,. Beta-lactam antibiotic resistance in aerobic commensal fecal flora of newborns. Pediatr Int 2005; 47: 267-73.
12. Amstey MS, Lewin E, Colaice J,. Vaginal colonization with invasive Escherichia coli during pregnancy. Am J Obstet Gynecol 1980; 137: 534-5.
13. Krohn MA, Thwin SS, Rabe LK, Brown Z, Hillier SL,. Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications. J Infect Dis 1997; 175: 606-10.
14. Tamelien R, Barčait E, Stonien D, Buinauskien J, Markūnien E, Kudrevičien A, et al. Escherichia coli colonization in neonates: prevalence, perinatal transmission, antimicrobial susceptibility, and risk factors. Medicina (Kaunas) 2013; 48: 71-6.
15. Villar HE, Aubert V, Baserni MN, Jugo MB,. Maternal carriage of extended-spectrum betalactamase-producing Escherichia coli isolates in Argentina. J Chemother 2013; [ www.chromagar.com/fichiers/1370954717joc218.pdf ]. Accessed 22 September 2013.
16. Dave J, Millar M, Haigh J, Meade R, McEwan R, Phee LM, et al. Enhanced surveillance for multi-drug resistant bacteria during the Olympic period. Public Health England Annual Conference; 2013 September 10-11; Warwick UK.
17. Polin RA, Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129: 1006-15.
18. McDonald LC, Bryant K, Snyder J,. Peripartum transmission of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol 2003; 41: 2258-60.
19. Strus M, Pawlik D, Brzychczy-Wloch M, Gosiewski T, Rytlewski K, Lauterbach R, et al. Group B streptococcus colonization of pregnant women and their children observed on obstetric and neonatal wards of the University Hospital in Krakow, Poland. J Med Microbiol 2009; 58 (Pt 2): 228-33.
20. Dubois V, De Barbeyrac B, Rogues AM, Arpin C, Coulange L, Andre C, et al. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission. J Antimicrob Chemother 2010; 65: 1368-71.
21. Alicea-Serrano AM, Contreras M, Magris M, Hidalgo G, Dominguez-Bello MG,. Tetracycline resistance genes acquired at birth. Arch Microbiol 2013; 195: 447-51.
22. Birgy A, Mariani-Kurkdjian P, Bidet P, Doit C, Genel N, Courroux C, et al. Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131. J Clin Microbiol 2013; 51: 1727-32.
23. Zhang L, Kinkelaar D, Huang Y, Li Y, Li X, Wang HH,. Acquired antibiotic resistance: are we born with it? Appl Environ Microbiol 2011; 77: 7134-41.
24. de Vries LE, Vallès Y, Agers Y, Vaishampayan PA, García-Montaner A, Kuehl JV, et al. The gut as reservoir of antibiotic resistance: microbial diversity of tetracycline resistance in mother and infant. PLoS One 2011; 6: e21644.
25. Prelog M, Grif K, Decristoforo C, Würzner R, Kiechl-Kohlendorfer U, Brunner A, et al. Tetracycline-resistant Escherichia coli strains are inherited from parents and persist in the infant's intestines in the absence of selective pressure. Eur J Pediatr 2009; 168: 1181-7.
26. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1-12.
27. Francis S, Khan H, Kennea NL,. Infection control in United Kingdom neonatal units: variance in practice and the need for an evidence base. J Infect Prev 2012; 13: 158-62.
28. Lutsar I, Trafojer UMT, Heath PT, Metsvaht T, Standing J, Esposito S, et al. Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial. Trials 2011; 12: 215.
29. Patel G, Bonomo RA,. "Stormy waters ahead": global emergence of carbapenemases. Front Microbiol 2013; 4: 1-17.
30. Burns G, Plumb J,. GBS public awareness, advocacy, and prevention-What's working, what's not and why we need a maternal GBS vaccine. Vaccine 2013; 31 (Suppl 4): D58-65.
31. Petersen I, Gilbert R, Evans S, Ridolfi A, Nazareth I,. Oral antibiotic prescribing during pregnancy in primary care: UK population-based study. J Antimicrob Chemother 2010; 65: 2238-46.